Announcements Trials
Browse Landscape

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Breast Neoplasms 8Leukemia 6Leukemia, Myeloid, Acute 5Myelodysplastic Syndromes 3Lung Neoplasms 3Congenital Abnormalities 3Colorectal Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Sarcoma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Precancerous Conditions 2Monoclonal Gammopathy of Undetermined Significance 2Lymphoma 2Leukemia, Lymphocytic, Chronic, B-Cell 2Colonic Neoplasms 2Central Nervous System Neoplasms 2Waldenstrom Macroglobulinemia 1Uveal Melanoma 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Prostatic Neoplasms 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroblastoma 1Neoplasms, Plasma Cell 1Neoplasm Metastasis 1Myeloproliferative Disorders 1Myelodysplastic-Myeloproliferative Diseases 1

Interventions

Letrozole 2Anastrozole 2trastuzumab deruxtecan 1dalpiciclib 1Vinorelbine 1Standard of Care 1Safety 1Radiotherapy 1In Situ Hybridization, Fluorescence 1Gonadotropin-Releasing Hormone 1Aromatase Inhibitors 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Advanced Breast Cancer × In Situ Hybridization, Fluorescence × Clear all
NCT00874146 2010-09-02

Level of HER2-neu Gene Amplification an Response to Trastuzumab

Istituto Clinico Humanitas

Unknown
100 enrolled
Breast

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡